Xeris Biopharma (XERS) Q3 2023 Earnings

9NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.16
-0.11
-0.05
0

Details

Expected EPS
-0.12
Actual EPS
-0.09
Surprise EPS
0.03
Surprise Percent
+25%

Description

Xeris Biopharma (XERS) has reported earnings of -0.09 per share for Q3 2023.

0 Comments

Share your thoughts